EphA3 Directed CAR-T Cells for Treatment of Tumors
Copyright © Targeted News Service 2024
2024-11-12
ALEXANDRIA, Virginia, Nov. 12 -- MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Rochester, Minnesota has been assigned a patent (No. US 12139544 B2, initially filed Nov. 9, 2020) developed by three inventors Cameron Durrant, Oxford, Florida; Dale Chappell, Dolores, Colorado; and Saad J. Kenderian, Rochester, Minnesota, for "EphA3 directed CAR-T cells for treatment of tumors." . . .